carbamazepine has been researched along with sirolimus in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Butler, IJ; Koenig, MK; Muncy, J | 1 |
| Beligere, GS; Chen, YY; Fishpaugh, JR; Grote, J; Harwick, LC; Lin, Z; Nair, RK; Rege, SD; Rupprecht, KR | 1 |
| Guo, BS; Liu, YC; Shen, CK; Tsai, KJ; Wang, IF; Wu, CC; Yang, CH | 1 |
| Chen, X; Dong, XC; Li, M; Lin, CW; Xiong, X; Yin, XM; Zhang, H | 1 |
| Friedman, SL | 1 |
| Lin, F; Qin, ZH | 1 |
| Harris, PC; Lin, X; Sieben, CJ; Xu, X; Zhu, P | 1 |
| Che, H; Fu, P; Gao, Y; Pan, Y; Wang, L; Wang, R; Zhang, L | 1 |
2 review(s) available for carbamazepine and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Topics: Autophagy; Carbamazepine; Humans; Huntingtin Protein; Huntington Disease; Lithium; Mutant Proteins; Nerve Tissue Proteins; Oxazoles; Peptides; Rilmenidine; Sirolimus; Trehalose; Trinucleotide Repeat Expansion; Valproic Acid | 2013 |
11 other study(ies) available for carbamazepine and sirolimus
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Rapamycin reduces seizure frequency in tuberous sclerosis complex.
Topics: Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fructose; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Neurosurgical Procedures; Paresis; Seizures; Sirolimus; Topiramate; Treatment Outcome; Tuberous Sclerosis; Virus Diseases | 2009 |
Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs.
Topics: Acridines; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anticonvulsants; Carbamazepine; Collodion; Cyclosporine; Gentamicins; Hydrocortisone; Immunoblotting; Immunosuppressive Agents; Methotrexate; Pharmaceutical Preparations; Reproducibility of Results; Sirolimus; Tacrolimus | 2010 |
Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43.
Topics: Analysis of Variance; Animals; Autophagy; Blotting, Western; Carbamazepine; Caspase 3; Fluorometry; Frontotemporal Dementia; In Situ Nick-End Labeling; Maze Learning; Memory Disorders; Mice; Psychomotor Performance; Rotarod Performance Test; Sirolimus; Spermidine; Tamoxifen; TDP-43 Proteinopathies; TOR Serine-Threonine Kinases | 2012 |
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
Topics: Animals; Autophagy; Biomarkers; Carbamazepine; Cells, Cultured; Chloroquine; Dietary Fats; Disease Models, Animal; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Hepatocytes; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Non-alcoholic Fatty Liver Disease; Sirolimus | 2013 |
Focus.
Topics: Animals; Autophagy; Carbamazepine; Fatty Liver; Fatty Liver, Alcoholic; Non-alcoholic Fatty Liver Disease; Sirolimus | 2013 |
Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Carbamazepine; Cells, Cultured; Disease Models, Animal; Embryo, Nonmammalian; Epithelial Cells; Mice; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Sirolimus; TOR Serine-Threonine Kinases; TRPP Cation Channels; Zebrafish | 2017 |
Evaluating the Effectiveness of GTM-1, Rapamycin, and Carbamazepine on Autophagy and Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Autophagy; Carbamazepine; Disease Models, Animal; Hippocampus; Male; Maze Learning; Mice; Neurons; Neuroprotective Agents; Plaque, Amyloid; Quinazolines; Random Allocation; Sirolimus; Spatial Memory | 2017 |